Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Visual outcomes in pediatric optic neuritis.
The conundrum of interferon-β non-responsiveness in relapsing-remitting multiple sclerosis.
IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties.
An unusual case of 'itchy paralysis': neuromyelitis optica presenting with severe neuropathic itch.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
Modeling cognition and disease using human glial chimeric mice.
High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients.
Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis.
Novel therapeutic options for multiple sclerosis.
Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood brain barrier.
Role of Glia in Stress-Induced Enhancement and Impairment of Memory.
Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
Treatment Satisfaction With Disease Modifying Therapies In Multiple Sclerosis: A Systematic Review of Studies Using The Treatment Satisfaction Questionnaire For Medication (Tsqm).
Role of phospholipase A(2)s and lipid mediators in secondary damage after spinal cord injury.
Brachial plexus atrophy in chronic inflammatory demyelinating polyradiculoneuropathy.
Searching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis.
Goals set after completing a teleconference-delivered program for managing multiple sclerosis fatigue.
Cortical Lesions in Multiple Sclerosis: Clinical Relevance for a Hidden Disease Burden.
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future.
Virtual Sensory Feedback for Gait Improvement in Neurological Patients.
Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification.
Multiple sclerosis in a postgraduate student of anaesthesia: illness in doctors and fitness to practice.
Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum.
Pages
« first
‹ previous
…
671
672
673
674
675
676
677
678
679
…
next ›
last »